Janet G. Abaray Shareholder Burg Simpson Eldredge Hersh & Jardine, P.C. 312 Walnut Street Suite 2090 Cincinnati, OH 45202 Phone: (513) 852-5600 Email: firstname.lastname@example.org Website: http://www.burgsimpson.com/index.html Janet Gilligan Abaray acts as managing shareholder for the Cincinnati office of Burg Simpson Eldredge Hersh & Jardine, P.C. She received her Bachelor of Arts degree from the University of Cincinnati, graduating Phi Beta Kappa and summa cum laude. She graduated Order of the Coif from the University of Cincinnati School of Law where she was Business Manager of the Law Review. She is admitted to practice before the Supreme Court of Ohio, the United States Courts of Appeals for the Third, Sixth, Tenth and Eleventh Circuits and the United States Supreme Court. Ms. Abaray has litigated extensively in the area of pharmaceutical products liability, beginning her career as defense counsel for Merrell Dow Pharmaceuticals, Inc. in the Bendectin products liability class action and multi-district litigation (MDL), where she acted as third chair trial counsel. Since 1987, she has represented plaintiffs in many over-the-counter and prescription drug cases, including the L-Tryptophan MDL, the Copley Albuterol class action litigation, where she acted as co-lead trial counsel, and the Fen-Phen/Redux diet pill class action and MDL, where she acted as lead trial counsel for plaintiffs at the Interneuron class action fairness hearing. Currently, Ms. Abaray and Michael Burg are Co-Lead Counsel for Plaintiffs in the Ortho Evra Birth Control Patch Multidistrict Litigation pending in the Northern District of Ohio. In July 2008, Ms. Abaray was appointed to the Executive Committee for the Heparin Product Liability Multi-District Litigation. Ms. Abaray was appointed to this position by The Honorable James G. Carr, federal judge presiding over the Heparin Product Liability Multi-District Litigation in the Northern District of Ohio. The Executive Committee is charged with coordinating the responsibilities of the Plaintiffs' Steering Committee (PSC) including scheduling meetings of the PSC, keeping minutes or transcripts of those meetings, appearance at periodic court noticed status conferences, other necessary administrative or logistic functions of the PSC and any other duty as the Court may order. The PSC is responsible for the coordinated and consolidated conduct of all discovery on behalf of and for the benefit of all plaintiffs. Ms. Abaray has also been named to the Executive Committee in the Human Tissue Multidistrict Litigation, pending in the District of New Jersey, and she serves as Plaintiffs' Liaison Counsel and a member of the Plaintiffs' Coordinating Committee for the Ephedra Products Liability Multidistrict Litigation pending in the Southern District of New York. Ms. Abaray also represents plaintiffs in many insurance and contract disputes. She was the co-lead trial counsel on behalf of 8000 farmers in the Chubb drought insurance class action litigation, participated as trial counsel on behalf of 2000 Cincinnati area physicians in the ChoiceCare HMO litigation, and represented Cincinnati area newspaper carriers in consolidated actions against the Cincinnati Enquirer. She represented 40,000 season ticket holders of the Cincinnati Bengals football team in a successful class action concerning their seat licenses in Paul Brown Stadium. Ms. Abaray has established national precedent in the area of employment discrimination, successfully arguing in litigation against Ernst & Young to broaden the scope of persons protected by the federal age discrimination statute. Cincinnati Magazine recognized Ms. Abaray as one of Cincinnati's best litigation attorneys in 1995, and she was named an Ohio Super Lawyer for 2005, 2006, 2007, 2008 and 2009. Ms. Abaray has achieved the highest rating from her peers for quality of legal work, professionalism, and ethics by receiving an "AV" rating by Martindale- Hubbell. Ms. Abaray has served as a faculty member of the National Institute of Trial Advocacy and lectures frequently in the areas of products liability litigation, trial techniques and epidemiology. She has published articles in journals of the American Bar Association, Litigation Section, the Ohio Academy of Trial Lawyers Association, the University of Cincinnati Law Review and the University of Dayton Law Review. John Beisner Partner O'Melveny & Myers LLP 1625 Eye Street, NW Washington, D.C. 20006 Phone: 202-383-5370 Fax: 202-383-5414 Email: email@example.com Website: http://www.omm.com/johnbeisner John Beisner is the Chair of O’Melveny’s firmwide Class Actions, Mass Torts, and Aggregated Litigation Practice. John focuses on the defense of purported class actions, mass tort matters, and other complex litigation in both federal and state courts. Over the past 25 years, he has been involved in defending numerous major U.S. and foreign corporations in over 600 purported class actions filed in the federal and state courts of 40 states at both the trial and appellate court levels. Those class actions have concerned a wide variety of subjects, including antitrust/unfair competition, consumer fraud, RICO, ERISA, employment/discrimination, environmental, product-related, and securities class actions. He has also handled numerous matters before the Judicial Panel on Multi-district Litigation, and has also been responsible for proceedings before various federal and state administrative agencies, particularly the National Highway Traffic Safety Administration and the Consumer Product Safety Commission. John also regularly handles appellate litigation projects, having appeared in matters before the U.S. Supreme Court and the U.S. Courts of Appeals of the First, Second, Third, Fourth, Fifth, Sixth, Seventh, Eighth, Ninth, and District of Columbia Circuits, as well as the state appellate courts of Alabama, Arizona, California, Florida, Illinois, Indiana, Louisiana, Maryland, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New York, Ohio, Texas, and West Virginia. John is a frequent writer and lecturer on class action and complex litigation issues, and has been an active participant in litigation reform initiatives before Congress, state legislatures, and judicial committees. In recent years, he has testified numerous times on class action and claims aggregation issues before the U.S. Senate and House Judiciary Committees (particularly with respect to the Class Action Fairness Act of 2005) and before state legislative committees. Given the nature of his practice, John has been instrumental in managing numerous high visibility corporate crisis situations over the years, including media allegations of defects in consumer products, the ordering of consumer product recalls by NHTSA and the CPSC, lawsuits alleging company-wide employment discrimination, lawsuits alleging fraud in the health maintenance organization programs, lawsuits alleging the use of forced labor in foreign markets, the shutdown of a nuclear power plant by the Nuclear Regulatory Commission, and regulatory charges of improprieties in the financial services industry. Serving in that crisis management role, John has dealt with intensive media coverage situations, congressional hearings, federal agency investigations, class action and mass tort litigation onslaughts, state attorney general inquiries, and General Accounting Office reviews. A list of numerous published federal and state court decisions in which John has played a role is available on request. Professional Activities Admitted to Practice, U.S. Supreme Court; U.S. Court of Appeals, First, Second, Third, Fourth, Fifth, Sixth, Seventh, Eighth, Ninth, and District of Columbia Circuits Member, American Bar Association; American Law Institute; ABA Class Actions Task Force Participant, Litigation reform initiatives Witness, Class action and claims aggregation issues before the U.S. Senate and House Judiciary Committees and before state legislative committees Writer and Lecturer, Class action and complex litigation issues Elizabeth J. Cabraser Partner Lieff, Cabraser, Heimann & Bernstein, LLP Embarcadero Center West 275 Battery Street, Suite 3000 San Francisco, CA 94111-3339 Tel. (415) 956-1000 Fax. (415) 956-1008 Phone: (415) 956-1000 Fax: (415) 956-1008 Email: firstname.lastname@example.org Website: http://www.lieffcabraser.com/bios/cabraser.php Bar Information Admitted to practice in California (1978); California Supreme Court (1978); U.S. Supreme Court (1996); U.S. District Court, Northern District of California (1978), Eastern District of California (1979), Central District of California and Southern District of California (1992); U.S. Court of Appeals, Second Circuit (2000), Third Circuit (1994), Fifth Circuit (1992), Sixth Circuit (1992), Seventh Circuit (2001), Ninth Circuit (1979), Tenth Circuit (1992) and Eleventh Circuit (1992); U.S. Tax Court (1979); and U.S. District Court, District of Hawaii (1986). Education Balt Hall School of Law, University of California (J.D., 1978); University of California at Berkeley (A.B., 1975). Awards & Honors The Best Lawyers in America, 2005-2009; "Edward Pollock Award," Consumer Attorneys of California, 2008; University of San Francisco School of Law Public Interest Law Foundation "Award For Public Interest Excellence," 2007; "Northern California Super Lawyer," Law & Politics, 2004-2008; "Top 100 Northern California Super Lawyer," Law & Politics, 2005-2007; "Top 50 Female Northern California Super Lawyer," Law & Politics, 2005- 2008; "50 Most Influential Women Lawyers in America," The National Law Journal, 1998 & 2007; "Top 100 Lawyers," California Daily Journal, 2002-2007; "Lawdragon 500 Leading Lawyers in America," Lawdragon, 2007- 2008; "Lawdragon 500 Leading Plaintiffs' Lawyers," Lawdragon, Winter 2007; "Top Women Litigators in California," The San Francisco and Los Angeles Daily Journal, 2007; "100 Most Influential Lawyers in America," The National Law Journal, 1997, 2000 & 2006; "Top 75 Women Litigators," California Daily Journal, 2005-2006; Distinguished Leadership Award, Legal Community Against Violence, 2006; Women of Achievement, Legal Momentum (formerly the NOW Legal Defense & Education Fund), 2006; "Top 30 Securities Litigator," California Daily Journal, 2005; "Top 50 Women Litigators," California Daily Journal, 2004; Citation Award, University of California, Berkeley Boalt Hall, 2003; "Top 30 Women Litigators," California Daily Journal, 2002; Distinguished Jurisprudence Award, Anti-Defamation League, 2002; "Top Ten Women Litigators," The National Law Journal, 2001; "California Law Business Top 100 Lawyers," California Daily Journal, 1998-2000; Matthew O. Tobriner Public Service Award, Legal Aid Society, 2000; Presidential Award of Merit, Consumer Attorneys of California, 1998; "Lawyers of the Year," California Lawyer, 1998; Public Justice Achievement Award, Public Justice, 1997. Publications Co-Author with Joy A. Kruse, Bruce Leppla, "Selective Waiver: Recent Developments in the Ninth Circuit and California," (pts. 1 & 2), Securities Litigation Report (West Legalworks May and June 2005); Author, "The Manageable Nationwide Class: A Choice-of-Law Legacy of Phillips Petroleum Co. v. Shutts," University of Missouri- Kansas City Law Review, Volume 74, Number 3, Spring 2006; Co-Author, with Fabrice N. Vincent, "Class Actions Fairness Act of 2005," California Litigation, Vol. 18, No. 3 (2005); Editor-in-Chief, California Class Actions Practice and Procedures (2003); co-author, "Decisions Interpreting California's Rules of Class Action Procedure," Survey of State Class Action Law, updated and re-published in 5 Newberg on Class Actions (ABA 2001- 2004); co-author, "Mass But Not (Necessarily) Class: Emerging Aggregation Alternatives Under the Federal Rules," ABA 8th Annual National Institute on Class Actions, New York (Oct. 15, 2004), New Orleans (Oct. 29, 2004); co- author, "2004 ABA Toxicology Monograph-California State Law," (January 2004); "Human Rights Violations as Mass Torts: Compensation as a Proxy for Justice in the United States Civil Litigation System"; co-author, with Fabrice N. Vincent, "Ethics and Admissibility: Failure to Disclose Conflicts of Interest in and/or Funding of Scientific Studies and/or Data May Warrant Evidentiary Exclusions," Mealey's December Emerging Drugs Reporter (December 2002); co-author, with Fabrice N. Vincent, "The Shareholder Strikes Back: Varied Approaches to Civil Litigation Claims Are Available to Help Make Shareholders Whole,"Mealey's Emerging Securities Litigation Reporter (September 2002); Coordinating Editor and co-author of California section of the ABA State Class Action Survey (2001-02); "Unfinished Business: Reaching the Due Process Limits of Punitive Damages in Tobacco Litigation Through Unitary Classwide Adjudication," 36 Wake Forest Law Review 979 (Winter 2001); "Symposium: Enforcing the Social Contract through Representative Litigation," 33 Connecticut Law Review 1239 (Summer 2001); "Equity for the Victims, Equity for the Transgressor: The Classwide Treatment of Punitive Damages Claims," 74 Tulane Law Review 2005 (June 2000); "Class Action Trends and Developments After Amchem and Ortiz," in Civil Practice and Litigation Techniques in Federal and State Courts (ALI-ABA Course of Study 1999); Contributor/Editor, Moore's Federal Practice (1999); "Life After Amchem: The Class Struggle Continues," 31 Loyola Law Review 373 (1998); "Recent Developments in Nationwide Products Liability Litigation: The Phenomenon of Non-Injury Products Cases, the Impact of Amchem and the Trend Toward State Court Adjudication," Products Liability (ABA February 1998); Contributor/Editor, California Causes of Action (1998); "Beyond Bifurcation: Multi-Phase Structure in Mass Tort Class Actions," Class Actions & Derivative Suits (Spring 1997); "The Road Not Taken: Thoughts on the Fifth Circuit's Decertification of the Castano Class," SB24 ALI-ABA 433 (1996); "Getting the Word Out: Pre-Certification Notice to Class Members Under Rule 23(d)(2)," Class Actions & Derivative Suits Newsletter (October 1995); "Mass Tort Class Action Settlements," 24 CTLA Forum 11 (Jan./Feb. 1994); "Do You Know the Way from San Jose? The Evolution of Environmental and Toxic Nuisance Class Actions," Class Actions & Derivative Suits (Spring 1994); "An Oracle of Change? Realizing the Potential of Emerging Fee Award Methodologies for Enhancing The Role and Control of Investors in Derivative and Class Action Suits," Principles of Corporate Governance (ALI October 1994); "How To Streamline Complex Litigation: Tailor a Case Management Order to Your Controversy," 21 The Brief 12 (ABA/TIPS Summer 1992); "The Applicability of the Fraud-On-The-Market Theory to Undeveloped Markets: When Fraud Creates the Market," 12 Class Action Reports 402 (1989); "Mandatory Certification of Settlement Classes," 10 Class Action Reports 151 (1987). Member California State Bar Association; American Bar Association (Past Co-Chair, Committee on Mass Torts; Committee on Class Actions and Derivative Suits; Tort and Insurance Practice Section (TIPS); Past Vice-Chair, Rules & Procedures Committee, Contributor, Civil Procedure & Evidence News Letter; Business Law Section, Corporate & Litigation Group; Litigation Section and Committee on Class Actions and Derivative Suits; Co-Chair, Committee on Mass Torts); ABA National Institute on Class Actions (Organizer/ Participant, 1997-2000); American Law Institute, (Council; Advisor, American Law Institute International Jurisdiction and Judgments and Aggregate Litigation Projects); Public Justice; National Center for State Courts Mass Tort Conference Planning Committee; Federal Bar Association, Northern District of California Chapter; Fight for Justice Campaign; (California State Liaison, Women Trial Lawyers Caucus); California Constitution Revision Commission, 1993-1996; Northern District of California Civil Justice Reform Act (CJRA) Advisory Committee, and Advisory Committee on Professional Conduct; Consumer Attorneys of California (CAOC); California Women Lawyers; Association of Business Trial Lawyers; Lawyer Delegate, Ninth Circuit Judicial Conference, 1992 1995; Bar Association of the Fifth Federal Circuit; Bay Area Lawyers for Individual Freedom; Bar Association of San Francisco (Past President, Securities Litigation Section; Board of Directors, 1997-1998; Past Member, Judiciary Committee); Lawyers Club of San Francisco; Queen’s Bench. Joseph Cook Vice President, White Plains NERA Economic Consulting 50 Main Street 14th Floor White Plains, NY 10606 tel: +1 914 448 4046 fax: +1 914 448 4040 email@example.com Education BS in economics, Texas A&M University PhD in economics, Texas A&M University JD, with Honors, University of Houston Law Center Dr. Cook specializes in antitrust, complex commercial disputes, intellectual property, and auctions and market design. He has testified on economic and econometric issues relating to market design, intellectual property, contract damages, and merger-related competitive effects. In the pharmaceutical industry, Dr. Cook has written and consulted on off-label promotion, life-cycle management, patent settlements and generic entry, authorized generics, pricing and reimbursement, price- fixing, and the competitive effects of mergers. He has also worked on intellectual property litigation and class actions relating to medical devices. In telecommunications, Dr. Cook has worked on economic issues, principally as a strategic advisor to buyers, governments, and private sellers in the auctioning of spectrum licenses in countries including the United Kingdom, Ireland, Egypt, Panama, Australia, the Netherlands, Switzerland, Germany, Belgium, Turkey, Denmark, and Taiwan. In transportation and shipping, Dr. Cook has worked on mergers and price-fixing matters, as well as on a tradable permits policy for locks on the inland waterways. In agricultural markets, Dr. Cook has consulted on beef, fed cattle, and tobacco. Dr. Cook has also consulted on antitrust issues in horse racing and golf. Dr. Cook has published in the Journal of Political Economy, the Journal of Economic Behavior and Organization, and Antitrust, among other journals. He has presented at meetings of the American Economic Association, National Council of Farmer Cooperatives, and the Licensing Executive Society, among other professional forums. Kenneth S. Geller Partner Mayer Brown LLP 1909 K Street, N.W. Washington, DC 20006-1101 Phone: (202) 263-3225 Fax: (202) 263-5225 Email: firstname.lastname@example.org Website: http://mayerbrown.com Kenneth Geller is Vice Chairman of the firm and a leading member of the Supreme Court & Appellate practice. Described by Chambers USA 2006 as “‘a standout lawyer in a very talented group’ . . . ‘extremely experienced and seasoned, with superb judgment,’” Ken has written or edited some 300 briefs and certiorari petitions and argued more than 40 cases before the US Supreme Court. Most recently, he was described by Chambers USA 2007 as “‘both incredibly organized and wonderfully clear. He is superb when you need someone to take a highly complex area of law and distill it to its essence.’” In 2007, Ken was listed among The Best Lawyers in America in the area of Appellate Law. Chambers USA 2004 named him to the top band of its "America’s Leading Lawyers for Business" list, noting that “Ken Geller has over 40 Supreme Court arguments under his belt, many of them for household names such as Ford, Chrysler and GM. ‘Never less than immaculately prepared,’ reported market observers, his is a familiar face in the highest courts, where he acts on cases of the ilk of American Insurance Association v Garamendi and National Park Hospitality Association v US DOI.” In 1983, Ken received the Presidential Award for Distinguished Service in the field of law. Ken joined Mayer Brown in 1986 and was named Vice Chairman of the firm in 2007. He was Partner-in- Charge of Mayer Brown’s Washington, DC office between 1995 and 2007, and has been a member of the firm’s Management Committee since 1995. Prior to joining the firm, Ken served as Deputy Solicitor General of the US Department of Justice (1979–1986) and as Assistant to the DOJ’s Solicitor General (1975–1979). Between 1973 and 1975, he worked as Assistant Special Prosecutor for the federal government’s Watergate Special Prosecution Force. Previously, he worked with a law firm in New York and, between 1971 and 1972, served as Law Clerk to The Honorable Walter R. Mansfield, US Court of Appeals for the Second Circuit. Education Harvard Law School, JD, magna cum laude, 1971; Editor, Harvard Law Review • The City College of New York, City University of New York, BA, magna cum laude, 1968 Admitted • US Court of Appeals for the Federal Circuit, 1999 • US Court of Appeals for the Armed Forces, 1998 • District of Columbia, 1986 • Supreme Court of the United States, 1975 • New York, 1972 • US Court of Appeals for the Second, Third, Fourth, Fifth, Sixth, Seventh, Eighth, Ninth, Tenth, Eleventh and District of Columbia — admissions between 1972 and 1996 Paul E. Greenberg Managing Principal and Director, Health Economics Analysis Group 111 Huntington Avenue, Tenth Floor Boston, MA 02199 Phone: (617) 425-8000 Fax: (617) 425-8001 Email: email@example.com Summary of experience Director of the firm's Health Economics practice, Paul Greenberg specializes in the economics of the health care sector, both in complex business litigation and in health outcomes research. He has consulted in a variety of cases involving claims of anticompetitive behavior, patent infringement, drug-related injury, and inappropriate marketing and pricing practices, and has developed damage assessments in a range of commercial litigation matters. Mr. Greenberg has consulted to pharmaceutical and biotechnology companies concerning the pharmacoeconomic profile of specific diseases and medical products and performed pharmacoeconomic studies for major biopharmaceutical companies. His health economics research has been published in key medical, health economics, and managed care journals. He was the lead author of the landmark cost-of- illness study that estimated the annual costs of depression, the most widely cited health economics article to appear in the medical literature since its publication. Mr. Greenberg is a Task Force Consultant to the Centers for Disease Control (CDC) Guide to Community Preventive Services Committee on Mental Health. He also serves on the editorial boards of PharmacoEconomics, the Journal of Medical Economics, The Open Pharmacoeconomics & Health Economics Journal, and Expert Opinion on Pharmacotherapy, and was for many years on the editorial board of Expert Review of Pharmacoeconomics and Outcomes Research. Thomas M. Greene Greene & Hoffman 33 Broad Street, 5th Floor Boston, MA 02109 Telephone: (617) 261-0040 Facsimile: (617) 261-3558 E-mail: firstname.lastname@example.org Thomas M. Greene is a founding partner at Greene & Hoffman. His practice has focused on representing clients in complex civil litigation. Over the course of the last four years, Mr. Greene has devoted most of his time to litigation involving pharmaceutical companies and to class action litigation. In 2003, Dateline NBC featured a case in which Mr. Greene represented the whistleblower in a False Claims Act case against Warner Lambert and Pfizer. This case was followed closely by The Wall Street Journal, and The New York Times. The case settled for $152 million and represented the largest recovery under the False Claims Act achieved without the intervention of the US Department of Justice. Mr. Greene has represented individuals and families in cases against some of the nation’s largest corporations including Merck, Bristol-Meyers Squibb, Warner Lambert, Pfizer, Schering-Plough, American Airlines, GTE, Mobil Auto Club, AISI Steel, Inc., Mitsubishi, and Peat Marwick. Mr. Greene understands the importance of being at the helm of multi-district litigation. He was appointed to the Plaintiff’s Steering Committee in the case of In Re Air Crash Disaster, a case which involved the crash of an American Eagle passenger plane in North Carolina. He also serves on the Steering Committee in a case that consolidated more than 80 class actions in Boston in the case of In Re Neurontin Sales and Marketing Practices. He is currently serving as Chairman of that Steering Committee. Mr. Greene is regularly invited to speak at national conferences and summits. He has addressed the medical and health care industry about the legal intricacies of off-label promotion of pharmaceuticals. In 2005, he was the keynote speaker at the 2nd Annual Pharmaceutical Marketing Compliance Congress, presenting “The Growing Role of Whistleblowers.” Mr. Greene received his BA degree from Boston College in 1974 and his JD degree from Suffolk University Law School in 1977 David Hart Senior Assistant Attorney General Oregon Department of Justice 1162 Court Street NE Salem, OR 97301-4096 Phone: (503) 934-4400 email@example.com David joined the Financial Fraud/Consumer Protection Section of the Oregon Department of Justice in 2000 after a 15 year career as a Physical Therapist practicing in Hospitals, Hospice, Nursing Homes and Home Health Agencies in New York City and Portland, Oregon. He has organized and led numerous mulistate actions by state Attorneys General relating to the marketing of pharmaceuticals and medical devices including settlements relating to the off-label promotion of Bextra®, Zyprexa®, and Neurontin®. David has degrees from Oberlin College (B.A. Government), New York University (B.S. Pathokinesiology), and a J.D. from the Northwest School of Law at Lewis and Clark College. Paul E. Kalb, M.D. Partner Sidley Austin LLP 1501 K Street, N.W. Washington, D.C. 20005 Phone: 202.736.8050 Fax: 202.736.8711 Email: firstname.lastname@example.org Website: http://www.sidley.com/kalb_paul PAUL E. KALB, M.D. heads the firm’s national Healthcare Group and is a member of the firm's Executive Committee. He principally represents drug and device manufacturers and institutional healthcare providers in criminal, civil, and administrative enforcement actions and related civil litigation involving healthcare fraud and abuse and off-label promotion. In that capacity, he has negotiated a number of ground-breaking settlement agreements and corporate integrity agreements. Representative clients in such matters that are public include Apria Healthcare Group, Inc., the Bayer Corporation, Eli Lilly and Company, Genentech, Inc., Magellan Health Services, Inc., Novo-Nordisk, Inc., Schering- Plough Corporation and Sun Healthcare Group, Inc. He also counsels manufacturers, providers, consultants, lenders and investors on enforcement issues. Dr. Kalb is a graduate of Yale Law School, where he was an editor of the Yale Law Journal. Prior to attending law school, he received his M.D. degree, magna cum laude, from the Boston University School of Medicine, completed his residency in Internal Medicine at the New York Hospital-Cornell Medical Center, and served as an attending physician at the Memorial Sloan-Kettering Cancer Center. He also was a visiting lecturer at Yale College in Medicine, Law and Public Policy. He is an author, along with Robert Fabrikant, Mark Hopson and Pamela Bucy, of Health Care Fraud: Enforcement and Compliance and the author (or co-author) of numerous articles in legal, medical, and industry publications. He speaks regularly at industry conferences and has also lectured on fraud and abuse issues at the Justice Department’s National Training Center. In 2004, 2005 and 2006 Dr. Kalb was named by BTI Consulting, on the basis of a survey of Fortune 1000 companies, as a member of the BTI Client Service All-Star Team for law firms. He is one of 5 lawyers nationwide to have been named in three separate years. He was given the highest ranking among U.S. lawyers in the “investigations” category in PLC’s 2006/07 survey of leading Life Science lawyers worldwide and has also been named as a leading lawyer in PLC’s worldwide Dispute Resolution survey. He is listed as a leader in the field of healthcare law by Chambers USA and named by Washingtonian Magazine as one of the “Top Lawyers in Washington.” Appeals Court from 1983 to 1984. Owen Lee Kwong Los Angeles Superior Court 111 North Hill Street, Department 98 Los Angeles, California 90012 (213) 974-6215 E-Mail: Okwong@LASuperiorCourt.org Present Assignment: Judge of the Los Angeles Superior Court -Alternate Dispute Resolution Department-Stanley Mosk Courthouse Appointment/Election: Appointed Judge by Governor Deukmejian on April 18, 1989, and elected in 1992 (unopposed) to the Los Angeles Municipal Court. Elevated/appointed by Governor Wilson on January 22, 1993, to the Los Angeles Superior Court, and elected in subsequent elections (unopposed). Other Judicial Office: Judge of the Municipal Court, Los Angeles Judicial District, Los Angeles County, April 21, 1989 (date of oath) to February 5, 1993; Supervising Judge Central Arraignment Courts 1989. February 5, 1993 (date of oath) to present: Judge of the Los Angeles Superior Court, Supervising Judge East District Juvenile Court 2000. Sat on Assignment (Pro Tem) Courts of Appeal, Division Seven (1998). Past Employement: Deputy Attorney General, Office of the Attorney General, California Department of Justice, Los Angeles, California (1974-1989 (Supervising Deputy Attorney General, Antitrust Section 1982-1989; served as Acting Assistant Attorney General, various periods during 1982-1989; and as Special Assistant to the United States Attorney General in antitrust matters, San Francisco, California 1985-1989); Worked as pharmacist during law school and after admission to practice law (including Interim Chief Pharmacist, Kaiser Permanente, Sacramento, California (1969-1970); Supervising Pharmacist, UCLA Medical Center, Los Angeles (1970-1984); Supervising Pharmacist Northridge Medical Center (1984-1988); Pharmacist USC Doheny Eye Clinic (1996-1999). Currently a licensed California Pharmacist working at Kaiser Permanente, Los Angeles, California (1999 to Present). Education: Juris. Doctor 1973 from University of California at Los Angeles (UCLA), School of Law (recipient, Certificate of Merit Moot Courts Honors Program); Bachelor of Science 1968, cum laude from University of Utah, School of Pharmacy, Salt Lake City, Utah; Associate of Arts from Sacramento City College, Sacramento, California and attended Sacramento High Schools and Stanford Junior High School, both in Sacramento, California. Publications: Two Volume California Pretrial Practice & Forms (2004) Kwong et al.; Journal of Consumer Attorneys Association for Southern California-Advocate Settlement As A Way Of Life (October 2005). Judge Kwong has consulted on various Continuing Education of the Bar (CEB) books and periodicals. Lectures and Seminars: Lecturer Civil Law, Practice and Procedure San Fernando Bar Association (1992); Negotiating Favorable Personal Injury Settlement (CEB 1994, Moderator and Speaker); Settlement and Negotiation 13th Annual Las Vegas Convention, Consumer Attorney Association of Los Angeles (October 1995), Settlement & Negotiation Three Views on Settlement, Consumer Attorneys Association of Los Angeles (MCLE January 25, 1996); Faculty, Mealey Publication, Mealey’s Settling the Long-Tail Claim Conference (June 5-6, 1997 Chicago, Illinois); Trying the Environmental Coverage Case (June 4-6, 1998 Amelia Island, Florida); California Insurance Conference (June 21-22, 2001 Pasadena, California); Insurance Allocation Conference (January 24, 2004 Pasadena, California) I have lectured on Code of Civil Procedure 170.6 and Courtroom Etiquette at the Asian Pacific American Trial Skills Institute at their First Annual-1991; Second Annual-1992, and Third Annual-1993. Lecturer and Participant for Southern California Chinese Lawyers Association SCCLA Virtual Reality Trial Skills Workshop: Experts and the Evidence Code (October 27-28, 2001) Los Angeles Superior Court; Lecturer California Judges Association “The Ongoing War to Understand Tax” Implications and Benefits of Tax Law in Facilitating Settlements (November 2003 Annual Meeting) San Francisco, California; Lecturer and Participant SCCLA Virtual Reality Trial Skills Workshop: Experts and the Evidence Code (February 21-22, 2004) Loyola Law School, Los Angeles, California; Volunteer Judge National Sexual Orientation Law Moot Court Competition (2004) UCLA School of Law Los Angeles, California. Membership: Former Member: Member and Chair of Judicial Council, Civil and Small Claims Advisory Committee (1996-1997); Chair and Member of Legislative Issue Committee (1996-1997); CJER, Planning Committee Civil Law and Procedure Institute (1996); Member, Liaison Subcommittee on Statistical Reporting, Judicial Council Administration Advisory Committee (1996-1997); Member, Jury Comment Review Subcommittee to the Blue Ribbon Commission on Jury System Improvement (1996); Member of Executive Committee Los Angeles Superior Court; California Judges Association (1995-1996); Member of CJER’s “Chapter of the Month” club that edited manuscripts for the California Judges Benchbooks; California Asian Pacific Judges Association (two term President and Member); Member, Asian Business League; Municipal Court Judges Association of Los Angeles; State Bar Judicial Advisory Committee on Legal Forms; Los Angeles Superior Court Executive Committee (two terms); Association of California Deputy Attorney Generals; Phi Delta Chi, Salt Lake City (Business Manager); Rho Chi Pharmacy Honor Society, Salt Lake City; President, UCLA Student Bar Association; Secretary, UCLA Student Bar Association; and Representative to UCLA Graduate Student Association. Member, California State Advisory Committee to United States Commission on Civil Rights. Awards and Commendations: Recipient Letter of Commendation (1987-88) from State Bar of California for pro bono legal services; and “Public Service Award” (1983) for pro bono legal services. Judge Kwong was selected as one of the Leading 500 Judges In America by the national law journal Lawdragon publications <Lawdragon.com> (Winter 2006). Bar Admission: Admitted to California Bar and to United States District Court for the Central District on June 18, 1974. United States Court of Appeals for the Ninth Circuit June 28, 1974. United States Supreme Court August 8, 1980. United District Court for the Eastern District February 9, 1981. United States Court of Appeals for the Seventh Circuit January 26, 1982. United States Court of Appeals - Temporary Emergency Spring 1985. United States District Court for the Northern District of California January 7, 1987. Born in Sacramento, California and enjoys skiing, playing tennis, bowling, traveling, rollerblading, bicycling and reading. Katharine Latimer Partner Spriggs & Hollingsworth 1350 I Street, N.W. Washington, DC 20005 Phone: (202) 898-5850 Fax: (202) 682-1639 Email: email@example.com Website: http://www.spriggs.com Ms. Latimer represents manufacturers, premises owners, contractors, and other corporate members of highly regulated industries in trials and appeals of matters involving such products as prescription and over-the-counter drugs (including anxiety treatments, obstetrical drugs, antifungals, cough/cold medicines, diet aids, and cancer therapies), prostheses, welding rods, pesticides and herbicides, and manufacturing-use chemical compounds (including detergents, solvents and polychlorinated biphenyls (“PCBs”)). She is experienced in mass tort, class action and multi-jurisdiction litigation, and she serves as national trial counsel, regional trial counsel and Multidistrict Litigation (“MDL”) defense steering committee member in complex toxics matters. She also counsels clients on due diligence, product registration and labeling issues, as well as federal and state reporting requirements. Ms. Latimer has extensive experience in Daubert proceedings and the presentation and cross-examination of expert witnesses in diverse medical and technical fields. She represents our clients in their most high- profile litigation, including cases involving death, encephalopathy, brain, lung and breast cancer and cancer clusters, stroke, Parkinson’s disease, myocardial infarction, immunological injury, endocrine disruption, and myriad other serious injuries, as well as cases involving very substantial alleged business losses. These cases cover the gamut of liability theories, including fraud, conspiracy and other intentional torts. Ms. Latimer regularly coordinates amicus curiae support for our clients’ positions and frequently drafts amicus curiae briefs. She lectures at international and national seminars and private conferences on various aspects of pharmaceutical products liability and toxic tort litigation defense. She is the Consulting Editor and a member of the Advisory Board for the Expert Evidence Reporter published by BNA, and she was an inaugural member of the Lexis/Mealey's Toxic Tort Defense Advisory Council, on which she served until 2007. She served as an editorial board member of Mealey’s Litigation Reports: Toxic Torts from 1992 until 1995. She is a member of the Defense Research Institute (DRI). Ms. Latimer served as judicial clerk to the Hon. Johanna L. Fitzpatrick of the Nineteenth Judicial Circuit of Virginia (now Chief Judge of the Virginia Court of Appeals). Robert A. Long Partner Covington & Burling LLP 1201 Pennsylvania Avenue, NW Washington, DC 20004-2401 Phone: 202.662.5612 Email: firstname.lastname@example.org Website: http://www.cov.com/rlong Robert Long is a partner who practices in the areas of appellate litigation, antitrust, and administrative law. He chairs the firm’s appellate and Supreme Court litigation group. Mr. Long has argued 14 cases before the U.S. Supreme Court and has played a substantial role in the briefing or oral argument of more than 100 cases in federal and state appellate courts. He was a law clerk to Justice Lewis F. Powell, Jr., of the U.S. Supreme Court and Judge John Minor Wisdom of the U.S. Court of Appeals for the Fifth Circuit. From 1990 to 1993, he served as an Assistant to the Solicitor General of the United States. He is recognized as a leading appellate lawyer in Best Lawyers in America (also listed for administrative law), Chambers USA: America's Leading Lawyers, Guide to the World's Leading Lawyers, Washingtonian "Top Lawyers," and Washington, D.C. Super Lawyers. Mr. Long is an adjunct professor at Georgetown University Law Center and has been an adjunct faculty member at the University of Virginia School of Law. Previous Experience • Assistant to the Solicitor General of the United States (1990-93) Honors and Rankings • Best Lawyers in America, Appellate Litigation and Administrative Law (2007-2008) • Chambers USA: America’s Leading Lawyers, Appellate Litigation (2007-2008) • Guide to the World’s Leading Lawyers, Appellate Litigation (2006) • Washingtonian Magazine "Top Lawyer" (2007) • Washington D.C. Super Lawyers, Appellate (2007-2008) Pro Bono • Lopez v. Gonzales (U.S. Supreme Court 2006). Mr. Long was lead Supreme Court counsel for Petitioner Lopez in this immigration case. The Court ruled for Mr. Lopez, holding that a drug crime is an "aggravated felony" for immigration law purposes only if it is a felony under the federal drug laws. Samson v. California (U.S. Supreme Court 2006). Mr. Long was lead Supreme Court counsel for the petitioner. The court held that suspicionless searches of parolees are permissible under the Fourth Amendment. • Gonzales v. Raich (U.S. Supreme Court 2005). Mr. Long was counsel of record for the respondents. The court held that Congress has power under the Commerce Clause to prohibit individuals from possessing locally produced cannabis for personal medical use, even if such use is authorized by state law and recommended by a physician. • Brown v. Legal Foundation of Washington, 538 U.S. 216 (2003). Mr. Long was counsel to amicus curiae Texas Equal Access to Justice Foundation. The court held that Interest on Lawyers Trust Accounts (“IOLTA”) programs do not violate the Takings Clause of the Fifth Amendment. Memberships and Affiliations • American Academy of Appellate Lawyers, Fellow • American Law Institute, Member • Edward Coke Appellate Inn of Court, Master and President-Elect • Georgetown University Law Center, Adjunct Professor (Administrative Law and Solicitor General Seminar • University of Virginia School of Law, Lecturer (Appellate Litigation Seminar) • New York University School of Law, Dwight D. Opperman Institute of Judicial Administration, Director • Historical Society of the District of Columbia Circuit, Trustee • The Barker Foundation, President of the Board of Trustees Kirsten Mayer Counsel Ropes & Gray One International Place Boston, Massachusetts 02110-2624 Phone: 617-951-7753 Fax: 617-235-0537 Email: email@example.com Website: http://www.ropesgray.com/kirstenmayer Practice Kirsten Mayer is counsel in the Boston office of Ropes & Gray. Since joining the firm in 1999, Kirsten has represented clients in criminal and civil matters involving federal and state law enforcement agencies as well as in complex class action and multi-district litigation. Professional Experience Kirsten has significant experience defending corporations and individuals in the health care industry in grand jury, civil, and administrative investigations by United States Attorneys Offices, Main Justice, the Office of the Inspector General of the U.S. Department of Health and Human Services, and various state agencies. She has represented clients in the pharmaceutical and medical device industries in off-label, anti-kickback, AWP, and Medicaid Rebate Program fraud matters. She has also represented academic medical center, for-profit hospital, and not-for-profit hospital clients in anti-kickback, Stark, coding, and clinical research billing investigations. Ms. Mayer represents clients in civil False Claims Act, consumer protection, and private class action litigation, and has advised clients with respect to fraud and abuse and compliance matters in the context of internal investigations and strategic transactions in the health care industry. In addition to her work for health care clients, Kirsten has represented clients from other industries in investigations by United States Attorneys Offices and the United States Securities and Exchange Commission, and in complex commercial litigation, including arbitration. Kirsten's work has included achieving dismissal of a federal False Claims Act whistleblower suit in which the United States had intervened, a complete verdict for the defense following a jury trial against the State of West Virginia in Charleston, West Virginia, and decisions by federal law enforcement to take no action against clients after grand jury, civil and administrative investigations. Education • 1998, J.D., magna cum laude, Harvard Law School; Article Editor, Harvard International Law Journal • 1995, M. Phil. (Philosophy), Columbia University • 1994, M.A. (Philosophy), Columbia University • 1991, B.A., magna cum laude, with Distinction in Philosophy, University of Pennsylvania; Phi Beta Kappa Valerie M. Nannery Center for Constitutional Litigation, PC 777 6th St NW Ste 250 Washington, DC 20001-3723 Phone: (202) 944-2814 Fax: (202) 965-0920 Email: firstname.lastname@example.org Valerie M. Nannery is Litigation Counsel at the Center for Constitutional Litigation, P.C., a national law firm based in Washington, DC. CCL represents the American Association for Justice, State Trial Lawyer Associations, and individuals in cases from the trial courts to the U.S. Supreme Court on constitutional access to justice issues, including caps on damages, immunity statutes, punitive damages, mandatory arbitration and federal preemption. After graduating from the University of Virginia School of Law in 2003, Ms. Nannery joined Public Citizen as the Alan Morrison Supreme Court Assistance Project Coordinator. Prior to joining CCL, Ms. Nannery was an associate at Quinn Emanuel Urquhart Oliver & Hedges, LLP in Los Angeles, CA. Bert W. Rein Partner Wiley Rein LLP 1776 K Street NW Washington, DC 20006 Phone: 202.719.7080 Email: email@example.com Mr. Rein, a founding partner of the firm, is widely recognized as a leading litigator and international law expert. He has been recognized by Legal Times as Washington's "Leading Food and Drug Lawyer," and named by Corporate Counsel as one of the "Best Lawyers in America" for excellence in business and commercial litigation, communications and antitrust law. REPRESENTATIVE EXPERIENCE • Specializes in using constitutional law issues, such as First Amendment and due process, to challenge emerging legislative and regulatory policy. • Counsels manufacturers and associations on health care policy and tort reform initiatives. • Represented major insurers in several prominent coverage declaratory judgment actions. • Guided Intelsat, the international satellite organization, through the intricacies of conversion from an intergovernmental organization to a private company. PROFESSIONAL EXPERIENCE • Director, U.S. Chamber of Commerce (1990-1994). • Reagan Administration Transition Teams for the U.S. Department of Justice and Federal Trade Commission (1981). • Special Assistant to the Undersecretary of State (1969-1970) and Deputy Assistant Secretary of State for Economic and Business Affairs (1970-1973), U.S. Department of State. • General Counsel, Community Learning & Information Network (1998-Present). • Key Issues Committee, Richard M. Nixon Presidential Campaign (1968). ASSOCIATION MEMBERSHIPS • American Bar Association (ABA), Section of Antitrust Law. • President, Association of Trial Lawyers of America (ATLA), International Trade Commission (Section 337) (1990-1991). AFFILIATIONS • Chairman, U.S. Chamber of Commerce Law Council (1987-1990). • Board Member, National Chamber Litigation Center (NCLC) (1990-Present). • The American Law Institute (ALI). • Advisory Committee to U.S. Sentencing Commission, Administrative Committee. • National Committee on Tourism (1971-1973). • Civil Aeronautics Board (CAB), Administrative Committee on Procedural Reform. HONORS & AWARDS • Recognized by Legal Times as Washington’s “Leading Food and Drug Lawyer” (2005). • Named a Washington, DC “Super Lawyer” by Super Lawyers magazine (2007-2009). • Named by Lawdragon as one of America’s 3,000 Leading Lawyers (2007). • Listed year after year in the “Best Lawyers in America” directory. Paul H. Rubin Department of Economics Emory University 324 Rich Building 1602 Fishburne Drive Atlanta, GA 30322-2240 Phone (404) 931-0493 Email: firstname.lastname@example.org Website: http://www.emory.edu/COLLEGE/ECON/Rubi.htm PAUL H. RUBIN is Samuel Candler Dobbs Professor of Economics and Law at Emory University in Atlanta and editor in chief of Managerial and Decision Economics. He is a Fellow of the Public Choice Society and former Vice President of the Southern Economics Association, and is associated with the American Enterprise Institute, Independent Institute, and the Technology Policy Institute. Dr. Rubin has been Senior Staff Economist at President Reagan's Council of Economic Advisers, Chief Economist at the U.S. Consumer Product Safety Commission, Director of Advertising Economics at the Federal Trade Commission, and vice-president of Glassman-Oliver Economic Consultants, Inc., formerly a litigation consulting firm in Washington. He has taught economics at the University of Georgia, City University of New York, VPI, and George Washington University Law School. Dr. Rubin has written or edited eleven books, and published over one hundred and fifty articles and chapters on economics, law, regulation, and evolution in journals including the American Economic Review, Journal of Political Economy, Quarterly Journal of Economics, Journal of Legal Studies, Journal of Law and Economics, the Yale Journal on Regulation, and Human Nature, and he frequently contributes to the Wall Street Journal and other leading newspapers. His work has been cited in the professional literature about 2200 times. Books include Managing Business Transactions, Free Press, 1990, Tort Reform by Contract, AEI, 1993, Privacy and the Commercial Use of Personal Information, Kluwer, 2001, with Thomas Lenard, Darwinian Politics: The Evolutionary Origin of Freedom, Rutgers University Press, 2002, and The Evolution of Efficient Common Law (edited), 2007, Elgar. He has consulted widely on litigation related matters and has been an advisor to the Congressional Budget Office on tort reform. He has addressed numerous business, professional, government, policy and academic audiences. EDUCATION • Ph.D., Economics, Purdue University, 1970 • B.A., University of Cincinnati, 1963 (Honors) ADDITIONAL PROFESSIONAL AFFILIATIONS • Board of Advisors, Independent Institute, since 2002. • Senior Fellow, Progress and Freedom Foundation, since 2000. • Adjunct Scholar: American Enterprise Institute, since 1992; Cato Institute, 1992-1998. • Columnist, Regulation (published by the Cato Institute), since 2006. • Advisor on Tort Reform, Congressional Budget Office, 2003. • Board of Advisors, Institute for Forensic Science Administration, Fairleigh Dickinson University • Instructor, “Economic Underpinnings of Consumer Protection Law,” FTC, 2003. • Editor In Chief: Managerial and Decision Economics, since 1994. RESEARCH AND TEACHING AREAS Law and Economics (Economics Departments, Business Students, Law Schools, and Practicing Attorneys); Industrial Organization and Antitrust; Transactions Cost Economics; Government and Business (Economics and MBA Students); Public Choice; Economics of Advertising and Safety; Regulation and Cost-Benefit Analysis; Microeconomics; Biological Evolution and Economics. Victor E. Schwartz Shook, Hardy & Bacon LLP 600 14th Street, NW Suite 800 Washington, DC 20005-2004 Phone: 202-662-4886 Fax: 202-783-4211 email@example.com Victor Schwartz is a partner in the Washington office of the Kansas City-based law firm of Shook, Hardy & Bacon L.L.P., and chairs its Public Policy Group. The focus of the practice is to integrate litigation, government affairs and public relations. Mr. Schwartz has an active appellate practice, and advises product manufacturers on liability issues. Mr. Schwartz was a professor and dean at the University of Cincinnati College of Law prior to entering the full time practice of law. He currently serves on the College’s Board of Visitors. He also served as Chairman of the Federal Inter-Agency Task Force on Product Liability at the Department of Commerce, and received the Secretary of Commerce’s Award for Professional Excellence. He helped draft the Uniform Product Liability Act and the Risk Retention Act. For more than two decades, Mr. Schwartz has been co-author of the most widely used torts casebook in the United States, Prosser, Wade and Schwartz’s Torts (11th ed. 2005). He also is author of the leading text, Comparative Negligence. Mr. Schwartz is a member of the American Law Institute (ALI) and served on all of the Advisory Committees to the Restatement (Third) of Torts. He was inducted as a Life Member of the ALI in 1997. Mr. Schwartz co-chairs the Civil Justice Task Force of the American Legislative Exchange Council. Sought by print and broadcast media, Mr. Schwartz is frequently quoted in The Wall Street Journal, Washington Post and The New York Times, and has appeared on Oprah, 60 Minutes, and network news programs. He and his Public Policy Group colleagues were the recipients of the Phillip Burton Award for Outstanding Legal Scholarship. Mr. Schwartz was awarded the Jeffersonian Award by the American Legislative Exchange Council, a group of more than 3,000 state legislators. In light of his accomplishments, the National Law Journal recently named Mr. Schwartz a third time as one of the 100 most influential attorneys in the United States, and the Washingtonian magazine once again has named him one of the top government relations specialists in the Nation’s capital. Mr. Schwartz obtained his A.B. summa magna laude from Boston University and J.D. magna cum laude from Columbia Law School. He is a member of the bars of New York, Ohio and the District of Columbia. Scott Stern Associate Professor of Management & Strategy Kellogg School of Management Northwestern University 2001 Sheridan Road Evanston, IL 60208 Phone: 847-491-4526 Fax: 847-467-1777 firstname.lastname@example.org Professor Stern is an Associate Professor of Management and Strategy at the Kellogg School of Management at Northwestern University. Stern is the co-organizer of the NBER Innovation Policy and the Economy Working Group and a Senior Fellow of the Searle Center on Law, Regulation and Economic Growth. He is an Associate Editor of Management Science, the Journal of Industrial Economics, the International Journal of Industrial Organization, serves on the Board of Management of the International Schumpeter Society, and has served on the editorial boards of the Antitrust Law Journal and the Journal of Business and Economics Statistics. In 2005, Stern was awarded the first Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship. Stern explores how innovation - the production and distribution of "ideas" - differs from more traditional economic goods, and the implications of these differences for business and public policy. Often focusing on life sciences industries, this research is at the intersection between industrial organization and the economics of technical change. Recent studies examine the determinants of R&D productivity, the role of incentives and organizational design on the process of innovation, and the drivers of commercialization strategy for technology entrepreneurs. Professor Stern graduated with a BA degree in Economics from New York University, and received his PhD in Economics from Stanford University in 1996. From 1995-2001, Stern was Assistant Professor of Management at the Sloan School at MIT, and, from 2001-2003, Stern was a Non-Resident Senior Fellow of the Brookings Institution. Areas of Expertise Management of Innovation, IP Clusters (Biotechnology) Entrepreneurship (Includes: Small Business Management) Industrial Economics Innovation Technology Thomas P Stossel, MD Translational Medicine Division Brigham & Women’s Hospital 1 Blackfan Circle, Karp 6 Boston, MA 02115 Tel 617 355 9001 Fax 617 355 9016 Email: Tstossel@partners.org Stossel was educated at Princeton University and Harvard Medical School, trained in internal medicine at the Massachusetts General Hospital and in hematology at Boston Children’s and Peter Bent Brigham Hospitals. He was head of Hematology and Oncology at Massachusetts General Hospital from 1976 until 1991, Co-Director of the Hematology Division at Brigham & Women’s Hospital through 2006, and is currently Director of the Division of Translational Medicine at that hospital and American Cancer Society Professor of Medicine at Harvard Medical School. From 1976-1980 he was a consultant to the US Department of State, investigating effects of microwaves on US Embassy personnel in Moscow, former USSR. Stossel’s basic research concerns fundamental mechanisms of cell motility. This research led to discoveries that may reduce critical care complications of major injury and impact blood platelet transfusion therapy. His policy interests concern physician and researcher interactions with private industry. He was President of the American Society for Clinical Investigation and Editor in Chief of its Journal of Clinical Investigation, served as President of the American Society of Hematology and received its Dameshek and Thomas Awards. He has been elected to Membership in The National Academy of Sciences, The American Academy of Arts and Sciences, and the Institute of Medicine. He currently is Editor in Chief of Current Opinion in Hematology, a member of the Lasker Awards Jury, the Board of Directors of Zymequest Corporation, Founding Scientist of Critical Biologics Corporation, a Trustee of the American Council on Science and Health and a Senior Fellow of the Manhattan Institute for Policy Research. He has been awarded honorary MD degrees from the Universities of Linköping (Sweden) and Geneva (Switzerland). Stossel has assisted his wife, Kerry Maguire DDS MSPH, Director of Professional Advocacy, Tom’s of Maine, Inc, in doing dental prevention and treatment in orphanages in Zambia, and they have established a 5013c non-profit corporation, Options for Children in Zambia. Stossel also has an Honorary Physician Position at University Teaching Hospital, Lusaka, Zambia, where he is working with Zambian physicians to create a sickle cell disease center. Wells Wilkinson Associate Director Prescription Access Litigation 30 Winter Street, 10th Floor Boston, MA 02108 Phone: (617) 275-2869 Fax: (617) 451-5838 Mobile: (857) 540-2333 Email: email@example.com Website: http://www.prescriptionaccess.org/ Wells G. Wilkinson is the Director of Prescription Access Litigation, a non-profit organization that fosters class-action litigation to end illegal drug industry practices that drive up prices and reduce access to needed medicines. Prescription Access Litigation, has a nationwide coalition of over 135 union, consumer, senior, and other advocacy organizations committed to promoting access to prescription drugs for all Americans. Since its start in 2001, PAL has involved over 36 PAL coalition member organizations and nearly fifty individual consumers as lead plaintiffs in 16 former and 15 current lawsuits, which have, to date, yielded 11 settlements covering hundreds of drugs, and returned just under $1 Billion to consumers, union benefit funds, and other insurers. A recent settlement (New England Carpenters v First Databank, 05-cv-11148- PBS) is estimated to save as much as $1 billion in future costs on over four hundred prescription drugs. Since joining Prescription Access Litigation in May of 2008, Mr. Wilkinson has overseen their litigation activities, and advocated on behalf of nationwide consumers in settlements and proceedings concerning the cancer drug Lupron, HIV-Aids drug Norvir. He prepared ‘citizen petitions’ to get six illegal on-line ads by three medical device manufacturers removed from the website YouTube.com, and urged more diligent regulation by FDA of on-line advertising of drugs and devices. Before becoming an attorney, Mr. Wilkinson spent several years conducting biochemistry research, followed by a decade organizing volunteer-led grassroots campaigns for healthcare and campaign finance reform. He received his undergraduate degree in Biology from Boston University, and his law degree from the New England School of Law. Sidney M. Wolfe, M.D. Director The Health Research Group Public Citizen 1600 20th Street, NW Washington DC, 20009 Phone: (202) 588-7735 Fax: (202) 588-7796 firstname.lastname@example.org Sidney Wolfe, MD has been the Director of the Health Research Group since its creation in 1971. In 1966 he began working at the National Institutes of Health where he did research on aspects of blood- clotting and on alcoholism. Dr. Wolfe met Ralph Nader in Washington, D.C. at a meeting of the American Patients Association, began advising Mr. Nader on health problems in America and helped in the recruitment of medical student volunteers who worked for Mr. Nader. Since 1995 he has been an Adjunct Professor of Internal Medicine at the Case Western Reserve University School of Medicine. His medical degree is from Case Western University in Cleveland, Ohio and his internship and residency were in internal medicine. He is currently a member of the Society for General Internal Medicine. His awards include receiving the MacArthur Foundation Fellowship in 1990. Since May of 2008, he has been a member of FDA’s Drug Safety and Risk Management Advisory Committee, a four-year term, and was recently elected to the Board of Directors of the NIH Graduate School, FAES: Foundation for Advanced Education in the Sciences. He is the Co-author of the book Worst Pills, Best Pills and the editor of a monthly newsletter on the same topic and the companion web site WorstPills.org. Allison M. Zieve Public Citizen Litigation Group 1600 20th Street, NW Washington, DC 20009 Phone: (202) 588-1000 Email: email@example.com Website: http://www.citizen.org/index.cfm Allison M. Zieve joined Public Citizen Litigation Group in August 1994. At the Litigation Group, Ms. Zieve's practice areas include public health (such drug safety and food labeling issues), consumer safety (such as automobile standards), open government, federal preemption, class action abuse, and first amendment issues (in the context of federal regulation and of the Internet). Many of her cases involve issues related to the Food, Drug, and Cosmetic Act and to regulation by the Food and Drug Administration. She has also litigated against the National Highway Traffic Safety Administration, the Department of Justice, and the Department of Health and Human Services, among other agencies. Among the cases litigated by Ms. Zieve are Riegel v. Medtronic, Inc., 552 U.S. __ (2008) (unsuccessful representation on issue whether medical device laws preempt damages claims brought by injured patients against device manufacturers), Warner-Lambert v. Kent, 522 U.S. __ (2008) (successful representation on issue whether exception to a Michigan law providing drug companies immunity from liability to injured patients is preempted), Will v. Hallock, 126 U.S. 952 (2006) (successful representation in case under Federal Tort Claims Act), Public Citizen v. Mineta, 340 F.3d 39 (2d Cir. 2003) (successful challenge under the Administrative Procedure Act to NHTSA regulation), Dusenbery v. United States, 534 U.S. 161 (2002) (unsuccessful due process challenge to notice of forfeiture), and Center for Auto Safety v. NHTSA, 244 F.3d 144 (D.C. Cir. 2001) (mixed result in Freedom of Information Act case). Ms. Zieve has published articles on preemption of state-law damages actions, tobacco regulation, and the Freedom of Information Act. She has also taught appellate advocacy as an adjunct professor at the American University's Washington College of Law. Ms. Zieve is admitted to the District of Columbia Bar and is admitted to practice before numerous federal courts. She received her A.B. magna cum laude from Brown University in 1986 and was graduated from Yale Law School in 1989.